Rhenman & Partners Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-29,778
| Closed | -$11.4M | – | 95 |
|
|
2025
Q2 | $11.4M | Buy |
29,778
+13,000
| +77% | +$4.68M | 1.44% | 28 |
|
|
2025
Q1 | $5.8M | Sell |
16,778
-17,601
| -51% | -$5.66M | 0.67% | 44 |
|
|
2024
Q4 | $10.3M | Sell |
34,379
-41,850
| -55% | -$14.6M | 1.06% | 38 |
|
|
2024
Q3 | $31M | Sell |
76,229
-5,771
| -7% | -$2.11M | 2.51% | 10 |
|
|
2024
Q2 | $26.3M | Sell |
82,000
-18,000
| -18% | -$5.85M | 2.53% | 13 |
|
|
2024
Q1 | $33.4M | Sell |
100,000
-9,000
| -8% | -$2.75M | 3.16% | 7 |
|
|
2023
Q4 | $29.5M | Buy |
109,000
+26,000
| +31% | +$6.43M | 2.95% | 6 |
|
|
2023
Q3 | $20.4M | Buy |
83,000
+18,500
| +29% | +$5.06M | 2.2% | 17 |
|
|
2023
Q2 | $19.6M | Sell |
64,500
-19,500
| -23% | -$5.42M | 2.06% | 20 |
|
|
2023
Q1 | $21.8M | Sell |
84,000
-6,000
| -7% | -$1.52M | 2.39% | 15 |
|
|
2022
Q4 | $21.6M | Buy |
90,000
+47,000
| +109% | +$10.5M | 2.25% | 13 |
|
|
2022
Q3 | $9.35M | Buy |
43,000
+18,000
| +72% | +$3.59M | 0.98% | 36 |
|
|
2022
Q2 | $4.2M | Buy |
+25,000
| New | +$5.37M | 0.48% | 57 |
|
|
2022
Q1 | – | Sell |
-59,000
| Closed | -$15.2M | – | 91 |
|
|
2021
Q4 | $15.2M | Sell |
59,000
-16,000
| -21% | -$3.92M | 1.01% | 38 |
|
|
2021
Q3 | $18.2M | Hold |
75,000
| – | – | 1.28% | 35 |
|
|
2021
Q2 | $15.5M | Hold |
75,000
| – | – | 1.05% | 42 |
|
|
2021
Q1 | $14.1M | Hold |
75,000
| – | – | 0.98% | 41 |
|
|
2020
Q4 | $12.3M | Hold |
75,000
| – | – | 1.01% | 44 |
|
|
2020
Q3 | $9.35M | Hold |
75,000
| – | – | 0.83% | 49 |
|
|
2020
Q2 | $7.28M | Sell |
75,000
-15,000
| -17% | -$1.56M | 0.79% | 49 |
|
|
2020
Q1 | $8.09M | Buy |
90,000
+20,000
| +29% | +$2.59M | 1.13% | 39 |
|
|
2019
Q4 | $10.3M | Sell |
70,000
-5,000
| -7% | -$671K | 1.13% | 38 |
|
|
2019
Q3 | $9.03M | Sell |
75,000
-61,164
| -45% | -$7.9M | 1.13% | 37 |
|
|
2019
Q2 | $18.4M | Buy |
+136,164
| New | +$17.2M | 2.03% | 18 |
|
|
2018
Q1 | – | Sell |
-58,886
| Closed | -$5.17M | – | 95 |
|
|
2017
Q4 | $5.17M | Buy |
58,886
+8,886
| +18% | +$714K | 0.7% | 52 |
|
|
2017
Q3 | $3.98M | Sell |
50,000
-44,707
| -47% | -$3.6M | 0.51% | 66 |
|
|
2017
Q2 | $8.26M | Sell |
94,707
-10,000
| -10% | -$846K | 1.19% | 29 |
|
|
2017
Q1 | $9.32M | Hold |
104,707
| – | – | 1.48% | 28 |
|
|
2016
Q4 | $7.75M | Sell |
104,707
-5,293
| -5% | -$396K | 1.49% | 25 |
|
|
2016
Q3 | $8.32M | Buy |
110,000
+10,000
| +10% | +$766K | 1.32% | 25 |
|
|
2016
Q2 | $7.7M | Sell |
100,000
-4,000
| -4% | -$316K | 1.37% | 26 |
|
|
2016
Q1 | $8.12M | Buy |
104,000
+8,000
| +8% | +$559K | 1.61% | 22 |
|
|
2015
Q4 | $6.49M | Sell |
96,000
-84,000
| -47% | -$5.86M | 0.98% | 41 |
|
|
2015
Q3 | $13.9M | Buy |
180,000
+111,000
| +161% | +$9.83M | 2.22% | 13 |
|
|
2015
Q2 | $6.26M | Sell |
69,000
-5,000
| -7% | -$401K | 0.75% | 44 |
|
|
2015
Q1 | $5.57M | Buy |
74,000
+33,000
| +80% | +$2.37M | 0.94% | 38 |
|
|
2014
Q4 | $3.01M | Sell |
41,000
-17,000
| -29% | -$1.19M | 0.87% | 40 |
|
|
2014
Q3 | $4.09M | Sell |
58,000
-2,000
| -3% | -$132K | 1.2% | 31 |
|
|
2014
Q2 | $3.38M | Sell |
60,000
-10,262
| -15% | -$541K | 1% | 31 |
|
|
2014
Q1 | $3.69M | Buy |
70,262
+15,262
| +28% | +$759K | 1.11% | 30 |
|
|
2013
Q4 | $2.62M | Buy |
+55,000
| New | +$2.54M | 1.03% | 41 |
|
Other funds holding HCA
Rhenman & Partners Asset Management's HCA Position: Q3 2025 in Review
Rhenman & Partners Asset Management sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 29,778 shares — an estimated $11.4M sold.
Rhenman & Partners Asset Management first reported a position in HCA in Q4 2013 and held it in 41 quarters. The position peaked at $33.4M in Q1 2024. 1,287 funds tracked by Wall St. Rank hold HCA as of Q3 2025.
- Rhenman & Partners Asset Management reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
- Rhenman & Partners Asset Management sold 29,778 HCA Healthcare shares in Q3 2025, an estimated $11.4M.
- Rhenman & Partners Asset Management first reported a position in HCA Healthcare in Q4 2013 and held it in 41 quarters.
- Rhenman & Partners Asset Management's HCA Healthcare position peaked at $33.4M in Q1 2024.
- 1,287 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.
Based on Rhenman & Partners Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.